S-Biomedic

Magdeburg, Germany Founded: 2013 • Age: 13 yrs Acquired By Beiersdorf
Probiotic cosmetics for skin care are developed by S-Biomedic.

About S-Biomedic

S-Biomedic is a company based in Magdeburg (Germany) founded in 2013 was acquired by Beiersdorf in December 2022.. S-Biomedic has raised $6.86 million across 5 funding rounds from investors including dsm-firmenich, Beiersdorf and European Union. S-Biomedic offers products and services including Living Skin Probiotics and Sencyr. S-Biomedic operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Magdeburg, Germany
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name S-Biomedic
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6.86 M (USD)

    in 5 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Beiersdorf

    (Dec 16, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of S-Biomedic

S-Biomedic offers a comprehensive portfolio of products and services, including Living Skin Probiotics and Sencyr. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Probiotics from skin microbes to restore microbiome balance.

Program that modulates acne-prone skin using microbiome technology.

People of S-Biomedic
Headcount 10-50
Employee Profiles 11
Board Members and Advisors 8
Employee Profiles
People
Jessica Vanspringel
Junior Technician
People
Amine Zorgani
Head of Microbiology R&D
People
Veronika Oudova
Co-founder, CEO
People
Lisa Beckermann
Junior Formulation Scientist

Unlock access to complete

Board Members and Advisors
people
Toni Gabaldon
Scientific Advisor
people
Harald Gollnick
Scientific Advisor
people
Holger Bruggemann
Scientific Advisor
people
Luis Serrano
Scientific Advisor

Unlock access to complete

Funding Insights of S-Biomedic

S-Biomedic has successfully raised a total of $6.86M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round
  • First Round
  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2021 Amount Series A - S-Biomedic Valuation EIC Fund
Feb, 2020 Amount Grant - S-Biomedic Valuation

investors

Feb, 2019 Amount Series A - S-Biomedic Valuation DSM
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in S-Biomedic

S-Biomedic has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include dsm-firmenich, Beiersdorf and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Government agency and accelerator focusing on innovative startups and SMEs
Founded Year Domain Location
Venture capital firm backed by Johnson & Johnson
Founded Year Domain Location
Venture capital firm focused on science and tech-driven startups
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by S-Biomedic

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - S-Biomedic

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

S-Biomedic Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of S-Biomedic

S-Biomedic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
CRISPR-engineered cell and gene therapies are developed for research applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on S-Biomedic

Frequently Asked Questions about S-Biomedic

When was S-Biomedic founded?

S-Biomedic was founded in 2013 and raised its 1st funding round 4 years after it was founded.

Where is S-Biomedic located?

S-Biomedic is headquartered in Magdeburg, Germany. It is registered at Magdeburg, Saxony-anhalt, Germany.

Is S-Biomedic a funded company?

S-Biomedic is a funded company, having raised a total of $6.86M across 5 funding rounds to date. The company's 1st funding round was a Series A of $4.53M, raised on Feb 09, 2017.

What does S-Biomedic do?

S-Biomedic was founded in 2013 in Magdeburg, Germany, where probiotic cosmetic products for skin care are developed. Live beneficial microbes are incorporated into these products for dermatological applications. Operations focus on the biotech and cosmetics sector, with the initial offering being a topical gel designed for acne skin recovery. Activities center on creating microbiome-based solutions for skin health.

Who are the top competitors of S-Biomedic?

S-Biomedic's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

What products or services does S-Biomedic offer?

S-Biomedic offers Living Skin Probiotics and Sencyr.

Who are S-Biomedic's investors?

S-Biomedic has 8 investors. Key investors include dsm-firmenich, Beiersdorf, European Union, EIC Fund, and Johnson & Johnson Innovation – JJDC.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available